Table 2 Univariate and multivariate analysis of the influence of various clinicopathological characteristics on the prognosis of patients
Characteristics | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
P | HR | 95%CI | P | HR | 95%CI | |
Age | ||||||
< 50 vs ≥ 50 years | 0.153 | 0.538 | 0.23–1.258 | |||
Gender | ||||||
Male vs female | 0.529 | 0.670 | 0.192–2.333 | |||
Clinical stage | ||||||
I–II vs III–IV | 0.642 | 1.220 | 0.528–2.815 | |||
N stage | ||||||
N0–N1 vs N2–N3 | 0.039 | 8.277 | 1.113–61.54 | 0.090 | 5.804 | 0.762–44.233 |
M stage | ||||||
M0 vs M1 | 0.053 | 7.460 | 0.975–57.052 | |||
miR-4721expression | ||||||
Low vs high | 0.007 | 3.931 | 1.441–10.723 | 0.036 | 2.956 | 1.071–8.163 |
FOXA1 expression | ||||||
Low vs High | 0.277 | 1.684 | 0.658–4.306 | |||